Entering text into the input field will update the search result below

Agios Pharmaceuticals hires new CEO

Jul. 12, 2022 4:06 PM ETAgios Pharmaceuticals, Inc. (AGIO)By: Preeti Singh, SA News Editor
  • Agios Pharmaceuticals (NASDAQ:AGIO) has appointed Brian Goff as CEO and a member of its board of directors.
  • Goff holds over 30 years of experience in the biopharmaceutical industry, serving as the executive vice president, chief commercial and global operations officer at Alexion Pharmaceuticals most recently.
  • Current CEO Jackie Fouse will transition to chair of board of directors. Current chairman David Schenkein will remain on the board as a director.
  • All changes are effective August 8, 2022.

Recommended For You


Have a tip? Submit confidentially to our News team. Found a factual error? Report here.

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.